Skip to main content
. 2017 Jan 19;8:5. doi: 10.3389/fimmu.2017.00005

Figure 1.

Figure 1

Gating strategy for antibody-dependent natural killer (NK) cell activation assay. (A–C) Donor blood (as a source of NK cells) was incubated with the serum/plasma test samples and human immunodeficiency virus (HIV) peptide pools for 5 h and then analyzed by flow cytometry. The lymphocytes were gated using FSC/SSC scatter. The NK cells were identified as CD3−CD56+ cells and assessed for surface CD107a expression and intracellular IFN-γ expression. (D) Representative dot plots for positive control (purified anti-CD16). (E) Unstimulated (DMSO equivalent solution) control. (F,G) Representative displays of ADCC responder (patient-1) and non-responder (patient-2) to HIV-1 Env-C peptide pool.